Lung Cancer: Targets and Therapy
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
- PublisherDOVE MEDICAL PRESS LTD
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 2390
- Publication Time16
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2008
- Publisher URL
- Website URL
- Plagiarism
- Publication Time16
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 38% |
| 4-6 | 50% |
| 7-9 | 13% |
| >9 | 0% |
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Lung Cancer: Targets and Therapy been publishing? 
The Lung Cancer: Targets and Therapy has been publishing since 2008 till date.
How frequently is the Lung Cancer: Targets and Therapy published?
Lung Cancer: Targets and Therapy is published Continuous publication.
Who is the publisher of Lung Cancer: Targets and Therapy?
The publisher of Lung Cancer: Targets and Therapy is DOVE MEDICAL PRESS LTD.
How can I view the journal metrics of Lung Cancer: Targets and Therapy on editage?
For the Lung Cancer: Targets and Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Lung Cancer: Targets and Therapy?
The eISSN number is 1179-2728 and pISSN number is 1179-2728 for Lung Cancer: Targets and Therapy.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.